Routine thyroid hormone treatment for organ donors ineffective and potentially harmful

Doctors managing deceased organ donors routinely treat the donors’ bodies with thyroid hormones in a bid to preserve heart function and increase the quantity and quality of hearts and other organs available for transplantation.

Very successful human clinical trial with the innovative antibacterial surface-treated implants receives approval for quick end of recruitment. – Biotech Investments

EQS-News: aap Implantate AG / Key word(s): Study/Study results Very successful human clinical trial with the innovative antibacterial surface-treated implants receives approval for quick end

September 25, 2024

Progress in early detection and screening methods for pancreatic cancer

The evolution of pancreatic cancer screening technologies is pivotal for early detection, addressing key challenges to enhance survival rates and patient care.

November 11, 2024

Novartis hands PeptiDream $180M upfront to extend radiopharma discovery pact

Novartis is looking to build on its radiopharma research machinery. The maker of Lutathera and Pluvicto has expanded its longstanding peptide discovery deal with PeptiDream

May 1, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.